Page last updated: 2024-10-30

leflunomide and Dengue

leflunomide has been researched along with Dengue in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, WL1
Ho, LJ1
Chen, PC1
Tsai, YT1
Hsu, ST1
Chang, DM1
Lai, JH1

Other Studies

1 other study available for leflunomide and Dengue

ArticleYear
Immunosuppressive effects and mechanisms of leflunomide in dengue virus infection of human dendritic cells.
    Journal of clinical immunology, 2011, Volume: 31, Issue:6

    Topics: Cell Differentiation; Cell Movement; Cells, Cultured; Chemokine CCL19; Chemokine CCL21; Dendritic Ce

2011